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Background: Heroin use is associated with many serious conse-
quences. While effective treatments exist, barriers to services
persist. Understanding service use and barriers to treatment can
structure treatment practice and target interventions for those
who are most at risk. Objectives: To describe patterns and corre-
lates of substance abuse service utilization and treatment barriers
among a nationally representative sample of heroin users. Methods:
Data for this study were derived from the National Epidemiologic
Survey on Alcohol and Related Conditions. This study focused on
lifetime heroin users (N = 150). Results: Fifty-nine percent of heroin
users reported receiving at least one treatment service. The most
common services used were 12-step programs, detoxification, and
rehabilitation. Approximately 44% reported at least one barrier to
treatment. The most common were lack of motivation and beliefs
that it could be managed alone. In a multivariate logistic regression,
having a heroin use disorder was associated with a greater
likelihood of receiving services (OR = 6.09) and experiencing a
barrier (OR = 11.11) compared to those without a disorder. Conclu-
sions: High rates of service use and barriers were observed for all
levels of heroin involvement. These findings underscore the impor-
tance of improving access to services for this group, even when full
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criteria for a drug disorder is not met. Integration of motivational
approaches is also needed within the most common services used.
Scientific Significance: To our knowledge, this is the first study to
describe patterns and correlates of service use using a nationally
representative community sample of heroin users.
Keywords: disparities, drug treatment, heroin use, treatment
utilization
Heroin use disorders are associated with significant conse-
quences for individuals and society. It is estimated that lost
productivity, crime, health, and social service expenditures due
to heroin use disorders costs the United States $21.9 billion
annually (1). Drug abuse related healthcare costs of heroin
use were approximately $15 billion in 2000 (2). Additionally,
heroin is highly addictive. Those individuals who use heroin
are more likely to develop DSM-IV (The Diagnostic and Statis-
tical Manual IV) dependence within two years of first use than
individuals who initiate use of any other substance (3).
Effective treatments exist for heroin use disorders (4–6).
Many heroin users rely on publicly funded health insurance to







































































2 ORION MOWBRAY ET AL.
to entering drug treatment (8). Furthermore, evidence shows
that persons with a heroin use disorder, as with other injection
drug use disorders, experience a large gap between the services
they receive and the services they need (9). Prior research
indicates that persons with a heroin use disorder sometimes
avoid treatment because they feel they can handle the problem on
their own, feel treatment will not help, or fear stigma associated
with treatment (10). The existing research on patterns of use
and barriers to treatment is needed to help inform strategies for
structuring treatment and targeting interventions for users with
and without a disorder.
The purpose of the current study is to describe patterns and to
identify correlates of service utilization and barriers to treatment
among a community-based nationally representative sample of
heroin users.
METHODS
The present study used data from the 2001–2002 National
Epidemiologic Survey on Alcohol and Related Conditions
(NESARC), which is a nationally representative survey of
43,093 noninstitutionalized U.S. residents aged 18 years and
older (11). This survey used the Alcohol Use Disorders and
Associated Disabilities Interview Schedule–DSM-IV version
(AUDADIS-IV). Descriptions of the NESARC survey, relia-
bility of AUDADIS-IV, sampling protocol, and related publica-
tions are described in detail in prior studies (12–14).
MEASUREMENT
Heroin Use
This study included all survey respondents who admitted to
using heroin at any time over the course of their lives. DSM-IV
criteria were used to classify subjects into one of three mutually
exclusive categories: lifetime heroin use (no disorder), lifetime
heroin abuse (without dependence), or lifetime heroin depen-
dence (with or without abuse).
Other Drug Use Disorders
Participants were classified as having another lifetime drug
use disorder if they met lifetime DSM-IV criteria (abuse or
dependence) for marijuana, cocaine or crack, tranquilizers,
stimulants, painkillers, other prescription drugs, inhalants or
solvents, hallucinogens, and sedatives. Participants were also
classified as having a lifetime DSM-IV alcohol use disorder
(abuse or dependence).
Sociodemographic Variables
Several sociodemographic and clinical variables were
assessed in this study: racial/ethnic groups, gender, marital
status, personal income, and age. Living area (urban or rural)
was classified using U.S. census criteria such that rural areas
consisted of any area located outside of urban areas or urban
clusters.
Service Utilization
Participants were asked to reply yes or no to the questions:
“Have you ever gone anywhere or seen anyone for a reason
that was related in any way to your use of medicines or
drugs—a physician, counselor, Narcotics Anonymous, or any
other community agency or professional?” “Did you ever in
your life talk to a medical doctor or other professional about
your use of drugs?” Participants who endorsed this question
were then asked whether they used any of 14 different treatment
services (see Appendix 1).
Drug Treatment Barriers
Participants were asked: “Was there ever a time when you
thought you should see a doctor, counselor, or other health
professional or seek any other help for your drug use, but you
didn’t go?” Participants who endorsed this question were then
asked whether they were impeded from going to treatment for
any of 27 possible barriers to getting help (see Appendix 1).
ANALYSES
Analyses were computed using SUDAAN Version 9.0 (15).
This system implements a Taylor series linearization to adjust
for the complex survey design. Chi-square tests were used to
make bivariate comparisons between each categorical variable
and dichotomous outcomes. Multivariate logistic regression
analyses were used to examine service utilization and barriers
to treatment while adjusting for sociodemographic and other
clinical variables.
RESULTS
Within the NESARC sample, 150 persons reported lifetime
heroin use (see Table 1). The sample was predominately White
(71.9%), aged 35 to 54 (69.3%), and male (74.3%). Over half
of the sample reported living in a rural area (61.1%). Regarding
clinical characteristics, 63% met criteria for a DSM-IV heroin
use disorder (abuse or dependence), 76% met lifetime criteria
for another drug use disorder, and 87% met criteria for a lifetime
alcohol use disorder.
Service Utilization
Of the sample of heroin users, 59% reported receiving at least
one type of drug treatment services. As described in Table 1,
Hispanics had the highest rate of service use (82.3%), followed
by Blacks (70.4%) and Whites (52.9%). Respondents with an
income of less than $20,000 annually were more likely to receive
services (78.2%), compared to persons at higher income levels.
The majority of persons with heroin dependence used some
form of service (81.4%), which was substantially higher than
those with heroin abuse (69.2%) or no disorder (33.8%). Having
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TABLE 1.
Sample description of heroin users.
Variable
Overall (N = 150)
% (SE)
Service Utilization
% (SE) Services χ2
Treatment Barriers
% (SE) Barriers χ2
Race
White 71.3 (9.67) 52.9 (6.35) 3.64∗ 40.8 (96.05) .80
Black 14.4 (2.47) 70.4 (9.58) 48.7 (9.39)
Hispanic 13.6 (2.83) 82.3 (7.22) 55.3 (11.00)
Urbanicity
Urban 38.8 (4.84) 59.7 (7.11) .01 42.3 (7.23) .07
Rural 61.1 (4.84) 58.9 (6.61) 45.0 (6.98)
Gender
Male 74.3 (4.16) 56.5 (6.00) .87 44.5 (5.73) .03
Female 25.6 (4.16) 66.9 (9.06) 42.3 (10.26)
Marital Status
Married 42.6 (5.22) 62.1 (7.92) .29 40.1 (7.97) .46
Separated/Divorced 25.4 (3.72) 53.9 (8.30) 42.0 (8.09)
Never married 31.9 (4.77) 59.6 (8.83) 50.6 (8.28)
Personal income1
$0 to $19,999 33.3 (4.80) 78.2 (6.02) 3.00∗ 55.7 (8.27) 1.35
$20,000 to $34,999 26.3 (4.25) 45.4 (9.41) 30.5 (7.91)
$35,000 to $69,999 25.9 (4.36) 54.2 (10.42) 46.6 (9.15)
$70,000 and over 14.5 (3.87) 50.0 (15.21) 36.9 (15.64)
Age
18 to 34 22.3 (4.58) 47.0 (12.37) 1.20 42.7 (10.97) .47
35 to 54 69.9 (4.82) 60.9 (5.88) 45.9 (5.75)
55 and over 7.8 (2.31) 77.6 (14.29) 30.6 (14.45)
Lifetime heroin grouping
No disorder 36.9 (4.79) 33.8 (8.30) 8.47∗∗ 21.6 (7.21) 8.62∗∗
Abuse 37.0 (4.67) 69.2 (7.41) 46.9 (8.45)
Dependence 26.3 (3.84) 81.4 (6.06) 71.1 (8.01)
Lifetime alcohol use disorder 87.5 (3.38) 60.7 (5.46) .51 46.8 (5.35) 2.80
Lifetime drug use disorder2 76.7 (4.41) 65.2 (5.37) 3.99∗ 49.1 (5.56) 3.22
1 Measured in dollars per year. 2 Non-nicotine drug use disorder. ∗ p < .05, ∗∗p < .01.
Table 2 provides a summary of the five most common types of
services utilized among persons with a lifetime history of heroin
use. The most common type was a 12-step program (Narcotics
or Alcoholics Anonymous) (49.5%), followed by detoxification
(43.5%) and rehabilitation (41.6%). Significant differences in
the prevalence of service use were observed for three of the five
most common services. Persons with heroin dependence showed
the highest prevalence of use for 12-step programs (69.0%) and
private physicians (47.3%); the prevalence of use of the other
types of services for this group was nearly equivalent to those
with heroin abuse. While 30% of those with a history of heroin
use but no heroin use disorder reported use of drug treatment
services, the prevalence of each type of service use was lower
for this group than those with abuse or dependence.
Multivariate logistic regression was used to identify factors
associated with any type of service use among heroin users while
controlling for confounding variables (see Table 1). This model
(χ2 = 36.96, p < .01, pseudo-R2 = .21) showed that persons
with heroin dependence had 6.09 times greater odds of service
utilization compared to those without a disorder (95% CI =
1.71–21.72). No significant differences were observed between
those with abuse and those without a disorder. None of the other
independent variables showed statistical significance.
Treatment Barriers
Of the sample of heroin users, 44% reported at least one
barrier to receiving services. As described in Table 1, Hispanics
reported the highest percentage of barriers to treatment (55.3%),
followed by Blacks (48.7%), then Whites (40.8%). Respon-
dents with an income of less than $20,000 annually reported
the highest percentage of barriers to treatment (55.7%). The
majority of persons with heroin dependence reported at least
one barrier to treatment (71.1%), following those with heroin
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TABLE 2.
Service utilization and treatment barriers among heroin users
Overall % (SE) No Disorder % (SE) Abuse % (SE) Dependence % (SE) χ2
Service Utilization N = 150 N = 46 N = 55 N = 49
Narcotics/Alcoholics/Cocaine
anonymous
49.5 (5.33) 31.0 (8.15) 53.9 (8.29) 68.9 (8.63) 4.67∗
Drug or alcohol detoxification
clinic
43.5 (5.14) 25.1 (8.11) 54.2 (8.14) 53.2 (8.33) 3.55∗
Drug or alcohol rehabilitation
program
41.6 (5.04) 29.4 (8.11) 47.8 (8.26) 49.8 (8.34) 1.96
Outpatient clinic 32.3 (5.07) 17.6 (7.36 40.2 (8.19) 41.7 (8.25) 2.91
Private physician/psychiatrist/
social worker
30.5 (4.94) 15.5 (5.64) 33.5 (8.38) 47.3 (8.26) 4.29∗
Treatment Barriers N = 64 N = 10 N = 21 N = 33
Didn’t want to go 38.6 (7.89) 45.2 (20.17) 23.5 (12.41) 42.2 (10.30) 1.30
Strong enough to handle it alone 37.3 (6.60) 26.7 (15.17) 30.8 (11.27) 47.5 (9.29) .91
Thought it would get better by
itself
35.0 (6.83) 44.3 (20.31) 25.8 (10.65) 39.4 (8.43) .51
Wanted to keep using 26.2 (6.62) 0 (.00) 20.4 (9.87) 42.5 (10.29) 4.16∗
Didn’t think anyone would help 24.3 (6.69) 44.2 (20.32) 16.5 (9.01) 22.7 (7.84) .56
∗p < .05.
least likely to report a barrier to treatment (21.6%). Among
those with another drug use disorder, 49.1% reported one or
more barriers to treatment.
Table 2 provides a summary of the most common treatment
barriers among persons with a lifetime history of heroin use. The
most common treatment barrier reported was not wanting to go
(38.6%), followed by feeling strong enough to handle it alone
(37.3%), and thinking the problem would get better by itself
(35.0%). Significant differences in treatment barriers by heroin
use disorder groups were observed in only one of the most
common reported barriers: less than half (42.5%) of persons
with heroin dependence reported they wanted to keep using the
medicine/drug, while only 20.4% of those with heroin abuse
and 0% of those with no heroin use disorder reported the same.
Multivariate logistic regression was used to identify
factors associated with experiencing a treatment barrier while
controlling for confounding variables (see Table 2). This model
(χ2 = 36.77, p < .01, pseudo-R2 = .21) showed that persons
with heroin dependence had 11.11 times greater odds of encoun-
tering a barrier to services compared to those without a heroin
use disorder (95% CI = 3.19–38.64).
DISCUSSION
This study examined service utilization and reported
treatment barriers among lifetime heroin users. To our
knowledge, this is the first study to describe a nationally
representative, community-based sample of lifetime heroin
users with a focus on rates and correlates of service use and
treatment barriers. The current study provides important trend
data from a community sample to improve the generalizability
of clinic findings. For example, previous clinic samples show
similar demographic characteristics as well as similar patterns
in treatment barriers (e.g., not wanting to go, no desire for
treatment) (16). This study also incorporated DSM-IV criteria
for the measurement of heroin use disorders (i.e., abuse and
dependence), as well as other disorders.
Overall, the study found a high rate of service use among
persons reporting lifetime use of heroin, including those with
and without a disorder. Those participants who met criteria
for either abuse or dependence were most likely to report
service use and barriers to treatment. The most common type
of service use was a 12-step program, followed by drug or
alcohol detoxification and rehabilitation programs. Given the
high rates of comorbidity of risk-behaviors among heroin users
(17), stronger linkages between the self-help community (i.e.,
12-step programs) and professional service organizations can
better meet the needs of this group (18).
Over one-third of heroin users endorsed not receiving
treatment because they did not want to go, they thought they
were strong enough to handle it alone or they thought the
problem would get better by itself. In contrast, no financial
or practical constraints (i.e., not having a way to get there,
need for child care) were among the top five reported barriers
to treatment. These findings help shed light on the cognitive
struggles associated with treatment barriers. Previous clinic
findings highlight importance of structural barriers (such as not
being able to afford treatment, lack of child care) (16). When
these bodies of work are paired together, a more complete picture
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We also observed that those heroin users who met criteria for
heroin use disorders were far more likely to report they wanted
to keep using compared to those who have used heroin but who
have not met criteria for abuse or dependence, which under-
scores the importance of motivational enhancements to promote
treatment engagement and adherence. Cognitive-behavioral
approaches, when paired with drug maintenance programs have
been shown in previous work to improve recovery rates of
heroin-related addictions, especially in higher-severity drug
users (19). These results also point to the importance of
assessing for heroin use in community-based settings, with
careful attention being made to differentiating between abuse
and dependence. While those with abuse are at risk of transi-
tioning to more serious levels of heroin involvement, a diagnosis
of dependence is often necessary to qualify for treatment
services in addition to understanding patterns of service use,
barriers, and outcomes.
While having a heroin use disorder was associated with
service use and barriers, other factors did not exhibit significant
associations. A few explanations are possible. First, only 150
individuals reported heroin use in the NESARC study. Although
this is adequate statistical power for the analyses conducted,
the measurement strategy may not have adequately captured
group differences. Heroin users may represent a special group
of substance users, in that the opportunity to use heroin is not
evenly distributed through the population. As a result, heroin
users based on a community sampling strategy may appear
to be more homogeneous after accounting for severity of use
problems. Finally, heroin users in this study are less often
from urban areas. Considering this is a community sample,
it is possible that those with the most serious forms of heroin
involvement were underrepresented.
LIMITATIONS
Our main variables of interest, service utilization and
treatment barriers, were not specific to heroin but were relevant
to drug use in general. While it is known that there are high
rates of substance use comorbidities (20), it is possible that
responses could relate to other substances and not heroin. The
NESARC did not take into account the timing and temporal
ordering of service use, which is critical to understanding the
natural history and treatment careers of heroin users. It is also
important to acknowledge the difficulty determining accuracy in
response rates for persons who have ever used heroin. However,
the results are consistent with findings from clinical samples
(16).
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APPENDIX 1. COMPLETE LIST OF SERVICE USAGE
CATEGORIES AND TREATMENT BARRIER RESPONSES
Service Usage
1. Ever went to narcotics/cocaine/alcoholics anonymous or
any 12-step meeting?
2. Ever went to family services or other social service agency?
3. Ever went to drug/alcohol detoxification ward/clinic?
4. Ever went to inpatient ward of psychiatric/general hospital
or community mental health program?
5. Ever went to outpatient clinic, including outreach and
day/partial patient program?
6. Ever went to drug/alcohol rehabilitation program?
7. Ever went to methadone maintenance program?
8. Ever went to emergency room because of medicine/drug
use?
9. Ever went to halfway house because of medicine/drug use?
10. Ever went to crisis center because of medicine/drug use?
11. Ever went to employment assistance program (EAP)?
12. Ever went to clergyman, priest, or rabbi because of
medicine/drug use?
13. Ever went to private physician, psychiatrist, psychologist,
social worker, or other professional?
14. Ever went to any other agency or professional?
Treatment Barriers
1. I did not seek help because I wanted to go, but health
insurance didn’t cover it.
2. I did not seek help because I didn’t think anyone could
help.
3. I did not seek help because I didn’t know any place to go
for help.
4. I did not seek help because I couldn’t afford to pay the bill.
5. I did not seek help because I didn’t have any way to get
there.
6. I did not seek help because I didn’t have the time.
7. I did not seek help because I thought the problem would get
better by itself.
8. I did not seek help because I was too embarrassed to discuss
it with anyone.
9. I did not seek help because I was afraid of what my boss,
family, friends or others might think.
10. I did not seek help because I thought I should be strong
enough to handle it alone.
11. I did not seek help because I was afraid they would put me
in the hospital.
12. I did not seek help because I was afraid of the treatment
they would give me.
13. I did not seek help because I hated answering personal
questions.
14. I did not seek help because the hours were inconvenient.
15. I did not seek help because a member of my family objected.
16. I did not seek help because my family thought I should go,
but didn’t think it was necessary.
17. I did not seek help because I can’t speak English very well.
18. I did not seek help because I was afraid I would lose my
job.
19. I did not seek help because I couldn’t arrange for childcare.
20. I did not seek help because I had to wait too long to get into
the program.
21. I did not seek help because I wanted to keep using the
medicine or drug.
22. I did not seek help because I didn’t think the medicine or
drug problem was serious enough.
23. I did not seek help because I didn’t want to go.
24. I did not seek help because I stopped using a drug or
medicine on my own.
25. I did not seek help because friends or family helped me stop
using a medicine or drug.
26. I did not seek help because I tried getting help before and it
didn’t work.
27. I did not seek help because of some other reason.
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